Upgrade to SI Premium - Free Trial

Form EFFECT Nasus Pharma Ltd

March 16, 2026 6:13 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 13, 2026 4:30 P.M.
Form: F-1
CIK: 0002029039
Company Name: Nasus Pharma Ltd
File Number: 333-293950

Categories

SEC Filings